Views
5 years ago

Volumen VII - Adultos mayores - Agosto 2013

  • Text
  • Alzheimer
  • Ansiedad
  • Psicosis
  • Ansiedad
  • Depresion
  • Vejez
  • Geriatria
  • Pacientes
  • Mayores
  • Adultos
  • Edad
  • Riesgo
  • Estudio
  • Envejecimiento
  • Zieher
Tratado de Psicofarmacología y Neurociencia Volumen VII Adultos mayores, una población vulnerable

A Kabanchik //

A Kabanchik // Actualización y generalidades del uso de psicofármacos en geriatría 49. Mcintyre RS, Mancini DA, Mccann S, Srinivasan J, Sagman D, Kennedy SH. Topiramate versus Bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder:a preliminary single-blind study. Bipolar Disord. 2002 .4 (3): 207-213. 50. Jeste DV; Barak Y, Madhusoodanan S, Grossman F, et al. International multisite doublé-blind trial of the atypical antipsychotics risperidone, olanzapine in 175 elderly patients with chronic schizophrenia. Am J Geriatr Psychiatry 2003; 11(6):638.47. erratum appears in Am J Geriatr Psychiatry 2004;12(1):49. 51. Schatzberg AF, Cole JO, Debattista CH. Cap 4 Antipsicóticos Manual de Psicofarmacología Clínica, Ars Medica Barcelona Madrid 4ta edición 2005 pp167-248. 52. Uchida H, Kapur S, Mulsant BH, Graff- Guerrero A, PollockBG, Mamo DC. Sensitivity of Older Patients to Antipsychotic Motor Side Effects: A PET Study Examining Potential Mechanisms. Am. J. Geriatr. Psychiatry. 2009; 17 (3):255-263. 53. Jano E, Johnson M,Chen H, Rajender R, Aparasu R.Determinants of atypical antipsychotic use among users in community-dwelling elderly 1996-2004. Curr Med Res Opin 2008; 24(3): 709- 716. 54. Kamble P, Chen H, Sherer J, Aparasu RR. Antipsychotic drug use among elderly nursing home residents in the United States .The American Journal of Geriatric Pharmacotherapy 2008. 6, (4): 187-197. 55. Douglas IJ, Smeeth L. Exposure to antipsychotics and risk of stroke: self controlled case series stud BMJ. 2008; 337: a1227. 56. Martínez Martínez L, Fernández MR Olivera, Piñeiro Corrales G. La mortalidad en pacientes con demencia tratados con antipsicóticos atípicos (olanzapina, quetiapina y ziprasidona. Hosp Farm. 2009 01 de Julio; 33 (4) :224-8. 57. Alexopoulos GS, Streim J, Carpenter D, Docherty JP. Expert Concensus Panel for Using Antipsychotic Drugs in Older Patients .J Clin Psychiatry 2004; 65 Suppl, 2:5-105. 58. Lipscombe LL, Lévesque L, Gruneir A, Fischer HD, Juurlink DN, Gill SS, et al. Antipsychotic drugs and hyperglycemia in older patients with diabetes. Arch Intern Med. 2009 Jul 27; 169(14):1282-9. 59. Jalbert JJ, Eaton CB, Miller SC, Lapane KL Antipsychotic use and the risk of hip fracture among older adults afflicted with dementia. J Am Med Dir Assoc. 2010 Feb; 11(2):120-7. 60. Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. A new study links the use of atypical antipsychotic medications with sudden cardiac death. N Engl J Med. 2009; 360:225-235. 61. Ostling S, Skoog I,. Psychotic Symptoms and Paranoid Ideation in a No demented Population_ Based sample of the very old. Arch Gen. Psychiatry. 2002; 59: 53-59. 62. Wong DF; Wagner HN; Dannals RF; Links JM, Frost JJ, Ravert HT: Effects of age and dopamine and serotonin receptors measured by positron emission tomography in the living human brain. Science1984; 226: 1393-1396. 63. Seeman PF; Bzowej NH; Guan HC; Bergeron C, Becker LE, Reynolds GP et al: Human brain dopamine receptors in children and aging adults. Synapse 1987(1): 399-404. 64. Seeman MV: Gender and the onset of Schizophrenia: Neurohumoral influences. Psychiatry Journal of the University of Otawa1981; 6:136-7. 65. Seeman MV: Current outcome in Schizophrenia: women versus men. Acta Psychiatr. Scand. 1986; 73: 609-617. 66. Howard R; Rabins PV, Seeman, MV, Jeste DV and the International Late- Onset Schizophrenia Group. Late – Onset Schizophrenia and Very Late- Onset Schizophrenia – Like. Psychosis: An International Consensus .Am. J. Psychiatry 2000.157; 172-178. EDITORIAL SCIENS 43

LM Zieher - M Zorrilla Zubilete // Tratado de Psicofarmacología y Neurociencia, Volumen VII. Adultos mayores, una población vulnerable 67. Harry MJ, Jeste DV, Late Onset- Schizophrenia: an overview. Schizophr. Bull 1988; 14:39-45. 68. Keith SJ, Regier DA, Rae DS: Schizophrenic disorders, in Psychiatric Disorders in America: The Epidemiologic Catchment Area Study .Edited by Robins LN, Regier DA, New York Free Press 1991.pp 32-52. 69. Castle DJ, Murray RM: The Epidemiologic of late onset –schizophrenia. Schizophr Bull 1993; 19: 691-700. 70. Cohen. CI, Vahia I, Reyes P , Diwan S ; Bankole AO, Palekar N et al. Focus on Geriatric Psychiatry : Schizophrenia in Later Life; Clinical Symptoms and Social Well- being. Psychiatr. Serv .2008.59; 232-234. 71. Van Citters AD, Pratt, S I, Bartels SJ, Jeste DV. Revisión basada en la evidencia de tratamientos farmacológicos y no farmacológicos para adultos ancianos con esquizofrenia. Editor S J Bartels Clínicas Psiquiátricas de Norteamérica. Psiquiatría geriátrica basada en la evidencia .Barcelona Ed Masson.2005. 28, (4):913-939. 72. Howanitz E, Pardo M, Smelson DA, Engelhart C, Eisenstein N Stern RG, et al. The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia. J .Clin Psychiatry 1999, 60(1) 41-4. 73. Ruskin PE, Nyman G, Discontinuation of neuroleptic medication in older outpatient schizophrenics: a placebo-controlled double-blind trial. J. Nerv Ment Dis 1991; 179 (4): 212.-4. 74. Kennedy JS; Jeste D, Kaiser CJ, Golshan S ,Maguire GA, Kinon BJ et al. Olanzapine versus haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial. Int. J Geriatr Psychiatry 2003; 18 (11) 1013-20. 75. Madhusoodanan S, Brenner R, Gupta S, Reddy H, Bogunovic O. Clinical experience with aripiprazole treatment in ten elderly patients with schizophrenia or schizoaffective disorder, retrospective case studies. CNS Spectr 2004, 9 (11):862-7. 76. Barak Y, Mazeh D, Plopski I , Baruch Y. Intramuscular Ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia. Am.J.Geriatr Psychiatry 2006,14 (7):629-33. 77. Tzimos A, Samokhalov V , Kramer M, Ford L , Glassmann- Mayer C , Lim P ,et al .Safety and tolerability of oral paliperidone extended-release tablets in elderly patients with schizophrenia. A double-blind placebo controlled study with 6 month open label extention. Am. J. Geriatric Psychiatry, January 2008,16 (1):31-43. 78. Riedel M, Eich FX ,Möller HJ. A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients. Eur Psychiatry 2008. 79. Gillis AJ, Mc Donald B. Unmasking delirium. Can Nurse 2006; 102(9) 18-24. 80. Lonergan E, Britton AM, Luxenberg J, Wyller T. Antipsicóticos para el delirio (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, número 3, 2008. Oxford, Update Software Ltd. Disponible en: http://www.update-software.com (Traducida de The Cochrane Library, Issue . Chichester, UK: John Wiley & Sons, Ltd.). 81. Han L, Mc Cusher J, Cole M, Abrahamowicz M, Primeau F, Elie M. Use of medication with anti-cholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients.Arch Interm. Med 2001, 161. 1099-1105. 82. Michaud L, Bula C, Berney A, Camus V, Voellinger R, Stiefel F et al Delirium Guidelines development group. Delirium Guidelines for General 83. Short MR, Winstead PS. Delirium Dilemma. Orthopedics 2007, 30.273-6. 84. Gleason OC. Delirium. Am. Fam Physician 2003; 67:1027-1034. 85. Olzbolt LB, Paniagua MA, Kaiser RM. Atypical antipsychotic for the treatment of delirium 44

Biblioteca

Av. García del Río 2585 Piso 12 A - C.A.B.A
+54 11 2092 1646 | info@sciens.com.ar

Editorial Sciens, Todos los Derechos Reservados 2015